ZA200706023B - Method and composition for treating mammalian diseases and injuries caused by the cover-expression of peroxynitrite - Google Patents

Method and composition for treating mammalian diseases and injuries caused by the cover-expression of peroxynitrite

Info

Publication number
ZA200706023B
ZA200706023B ZA200706023A ZA200706023A ZA200706023B ZA 200706023 B ZA200706023 B ZA 200706023B ZA 200706023 A ZA200706023 A ZA 200706023A ZA 200706023 A ZA200706023 A ZA 200706023A ZA 200706023 B ZA200706023 B ZA 200706023B
Authority
ZA
South Africa
Prior art keywords
peroxynitrite
expression
composition
cover
injuries caused
Prior art date
Application number
ZA200706023A
Other languages
English (en)
Inventor
Martin Alain
Original Assignee
North Cell Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Cell Pharmaceutical filed Critical North Cell Pharmaceutical
Publication of ZA200706023B publication Critical patent/ZA200706023B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
ZA200706023A 2005-02-11 2006-02-10 Method and composition for treating mammalian diseases and injuries caused by the cover-expression of peroxynitrite ZA200706023B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/056,759 US8076373B2 (en) 2001-09-11 2005-02-11 Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite

Publications (1)

Publication Number Publication Date
ZA200706023B true ZA200706023B (en) 2009-01-28

Family

ID=36793380

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706023A ZA200706023B (en) 2005-02-11 2006-02-10 Method and composition for treating mammalian diseases and injuries caused by the cover-expression of peroxynitrite

Country Status (10)

Country Link
US (1) US8076373B2 (zh)
EP (1) EP1855721B1 (zh)
JP (1) JP5634011B2 (zh)
CN (2) CN101115505A (zh)
AU (1) AU2006213755B2 (zh)
CA (1) CA2597395C (zh)
IL (1) IL184403A0 (zh)
MX (1) MX2007009557A (zh)
WO (1) WO2006086643A1 (zh)
ZA (1) ZA200706023B (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002254525B2 (en) * 2001-04-04 2004-12-23 Critical Therapeutics, Inc. Method for preventing acute renal failure
US8076373B2 (en) * 2001-09-11 2011-12-13 North Cell Pharmacetical Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
SE0602446L (sv) * 2006-11-16 2008-05-17 Entress Ab Ny användning av kända farmakologiskt aktiva kemiska sammansättningar
US20100303888A1 (en) * 2007-04-18 2010-12-02 Jake Barralet Composition for enhancing bone formation
WO2013187891A1 (en) * 2012-06-13 2013-12-19 Alain Martin Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
US11006629B2 (en) 2008-11-20 2021-05-18 Armis Biopharma, Inc. Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same
US8445717B2 (en) * 2008-11-20 2013-05-21 Chd Bioscience, Inc. α-Keto alkylperacids and methods for producing and using the same
US8426634B2 (en) 2008-11-20 2013-04-23 Chd Bioscience, Inc. α-keto peracids and methods for producing and using the same
US11284621B2 (en) 2010-04-15 2022-03-29 Armis Biopharma, Inc. Compositions comprising peroxyacid and methods for producing and using the same
US20140113000A1 (en) 2012-10-18 2014-04-24 Chd Bioscience, Inc. Compositions Comprising Peroxyacid and Methods for Producing and Using the Same
MX2013009175A (es) * 2011-02-17 2013-08-29 Chd Bioscience Inc Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
US9044527B2 (en) 2011-02-17 2015-06-02 Chd Bioscience, Inc. Wound care products with peracid compositions
PL2897604T3 (pl) 2012-09-19 2018-10-31 Grespo Ab Kompozycje do ulepszenia funkcji mózgu
US9578879B1 (en) 2014-02-07 2017-02-28 Gojo Industries, Inc. Compositions and methods having improved efficacy against spores and other organisms
CA2953387C (en) * 2014-06-30 2023-11-28 The Regents Of The University Of California Ketobutyrate compounds and compositions for treating age-related symptoms and diseases
CN105417673B (zh) * 2015-11-16 2017-11-03 哈尔滨工业大学 一种利用单线态氧除藻的方法
US20200237815A1 (en) 2017-02-24 2020-07-30 Alain Martin Methods for treatment of lung damage and for inhibition of lung fibrosis
EP3648603A4 (en) * 2017-07-07 2021-04-14 Armis Biopharma, Inc. ANTIMICROBIAL, DISINFECTANT AND HEALING COMPOSITIONS AND THEIR PRODUCTION AND USE METHODS
EP3654771A1 (en) 2017-07-18 2020-05-27 Agrimetis, LLC Methods for the purification of l-glufosinate
WO2019038655A1 (en) * 2017-08-21 2019-02-28 The Regents Of The University Of California COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
US11253496B2 (en) 2017-11-29 2022-02-22 Edgar L. Hull Alpha keto acid compositions for treating hypo-albuminemia
IL256675A (en) 2017-12-31 2018-02-28 Technion Res & Development Found Ltd Methods and preparations for the prevention and treatment of pressure sores
US20210161845A1 (en) * 2018-08-21 2021-06-03 The USA, as reprsented by the Secretary, Dept. of Health and Human Services Methods of metabolic regulation of mitochondria for treating neural injury and neurological disorders
WO2021023264A1 (zh) * 2019-08-06 2021-02-11 连云港金康和信药业有限公司 用于治疗非洲猪瘟的药物组合物及其用途
EP3797766A1 (en) * 2019-09-24 2021-03-31 Evonik Operations GmbH Compositions for use in reducing inflammation
CN113694198A (zh) * 2020-05-23 2021-11-26 陈燕 一种从植物及中药材中提取抗病毒成分制造的药剂及方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2498165A (en) * 1946-05-29 1950-02-21 Balbina A Johnson Process for producing bacitracin
US2565057A (en) * 1946-12-21 1951-08-21 Burroughs Wellcome Co Polymyxin antibiotic
US2799620A (en) * 1956-06-29 1957-07-16 Rutgers Res And Educational Fo Neomycin and process of preparation
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4234599A (en) * 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5296370A (en) * 1990-10-04 1994-03-22 Rutgers, The State University Repair medium for the resuscitation of injured cells
US5602183A (en) 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5674912A (en) 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
US5652274A (en) 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
US5663208A (en) * 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same
US5658957A (en) 1991-03-01 1997-08-19 Warner Lambert Company Immunostimulating wound healing compositions and method for preparing and using same
US5981606A (en) 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5641814A (en) * 1991-03-01 1997-06-24 Warner-Lambert Company Antikeratolytic-wound healing compositions and methods for preparing and using same
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
US5633285A (en) * 1991-03-01 1997-05-27 Warner-Lambert Company Cytoprotective wound healing compositions and methods for preparing and using same
US5658956A (en) 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5614561A (en) 1991-03-01 1997-03-25 Warner-Lambert Company Antihistamine-wound healing compositions and methods for preparing and using same
US5646190A (en) * 1991-03-01 1997-07-08 Warner-Lambert Company Acne treating-wound healing compositions and methods for preparing and using same
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
US5692302A (en) 1991-03-01 1997-12-02 Warner-Lambert Company Razor cartridges comprising wound healing compositions and methods for preparing and using same
US5874479A (en) 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
PH31403A (en) * 1991-03-01 1998-10-29 Warner Lambert Co Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same.
EP0614359A1 (en) * 1991-11-26 1994-09-14 Warner-Lambert Company Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
US5256697A (en) * 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
JP2919731B2 (ja) 1993-12-28 1999-07-19 三洋電機株式会社 負電圧発生回路
NZ306832A (en) * 1995-09-19 2001-04-27 Cellular Sciences Inc Compositions for treating mammalian diseases caused by inflammatory response
US5798388A (en) * 1996-09-06 1998-08-25 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
US5891422A (en) 1996-10-10 1999-04-06 Warner-Lambert Company Antimicrobial composition containing a C3 -C6 alcohol
DE60038100T2 (de) 1999-02-26 2009-02-12 Johnson & Johnson Consumer Companies, Inc. Bioadhäsive antibakterielle wundheilungszusammensetzungen
JP2004528307A (ja) * 2001-03-15 2004-09-16 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション サイトカインにより媒介される炎症性状態の治療のためのピルベートおよび／またはその誘導体の使用方法
US6689810B2 (en) * 2001-08-21 2004-02-10 Cellular Sciences, Inc. Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
US6623723B2 (en) * 2001-08-21 2003-09-23 Cellular Sciences Inc. Method for treating bronchial constriction and bronchospasm
US8076373B2 (en) * 2001-09-11 2011-12-13 North Cell Pharmacetical Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
US7122578B2 (en) * 2001-09-11 2006-10-17 Alain Martin Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
US20040220265A1 (en) * 2002-07-25 2004-11-04 Celluar Sciences, Inc. Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide

Also Published As

Publication number Publication date
CN104998264B (zh) 2020-09-15
MX2007009557A (es) 2008-01-11
US8076373B2 (en) 2011-12-13
AU2006213755B2 (en) 2011-08-11
JP2008530115A (ja) 2008-08-07
US20050197397A1 (en) 2005-09-08
IL184403A0 (en) 2007-10-31
CA2597395A1 (en) 2006-08-17
WO2006086643A1 (en) 2006-08-17
EP1855721A1 (en) 2007-11-21
EP1855721B1 (en) 2014-09-10
JP5634011B2 (ja) 2014-12-03
CA2597395C (en) 2014-03-25
CN104998264A (zh) 2015-10-28
EP1855721A4 (en) 2010-06-02
AU2006213755A1 (en) 2006-08-17
CN101115505A (zh) 2008-01-30

Similar Documents

Publication Publication Date Title
ZA200706023B (en) Method and composition for treating mammalian diseases and injuries caused by the cover-expression of peroxynitrite
TWI348891B (en) Composition for preventing plant diseases and method for preventing the diseases
IL185256A0 (en) Method and composition for treating peripheral vascular diseases
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
IL187238A0 (en) Compositions and methods for treating hyperproliferative epidermal diseases
ZA200707407B (en) Composition for preventing plant diseases and method for preventing the diseases
GB0525041D0 (en) Methods, assays and compositions for treating retinol-related diseases
HK1109062A1 (en) Compositions and methods of use for treatment of mammalian diseases
IL182643A0 (en) Novel composition and methods for the treatment of immune related diseases
EP1924236A4 (en) SUNLESS TANNING COMPOSITION AND SOLAR TANNING PROCESS
EP1974370A4 (en) MICROGRAVIDE COMPOSITION AND METHOD OF USE
IL188919A (en) Process for the preparation of mandipropamide and its derivatives as well as its intermediates
EP1796675A4 (en) COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISEASES
PL1937626T3 (pl) Sposób i związki do otrzymywania salmeterolu
EP1740221A4 (en) METHOD AND COMPOSITIONS FOR TREATING POLYCYSTIC DISEASES
HK1119953A1 (en) Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
EP1929881A4 (en) EMULSION COMPOSITION AND PROCESS FOR PREPARING THE SAME
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP1865952A4 (en) COMPOSITIONS CONTAINING HISTAMINES FOR THE TREATMENT OF ALLERGIES
EP1781318A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF POLYKYSTIC DISEASES
EP1993564A4 (en) METHOD AND COMPOSITION FOR TREATING ALLERGIC DISEASES
EP1962882A4 (en) COMPOSITIONS AND METHOD FOR TREATING DIABETES
GB0519334D0 (en) Method and composition for treating skin
HU0401379D0 (en) Process for the preparation of risperidon
EP1854844A4 (en) POLYANILINE CONTAINING COMPOSITION AND PROCESS FOR PRODUCING THE SAME